Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Microphthalmia-Associated Transcription Factor (MITF) (Middle Region) Peptide

MITF Reactivity: Mouse Host: Synthetic BP, WB
Catalog No. ABIN980096

Quick Overview for Microphthalmia-Associated Transcription Factor (MITF) (Middle Region) Peptide (ABIN980096)

Target

MITF (Microphthalmia-Associated Transcription Factor (MITF))

Origin

Mouse

Source

  • 3
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Sequence

    DDIISLESSY NEEILGLMDP ALQMANTLPV SGNLIDLYSN QGLPPPGLTI

    Characteristics

    This is a synthetic peptide designed for use in combination with anti-Mitf Antibody(ARP37860_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Application Notes

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handling Advice

    Avoid repeated freeze-thaw cycles.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    MITF (Microphthalmia-Associated Transcription Factor (MITF))

    Background

    The function of this protein remains unknown.

    Alias Symbols: MGC124309, MGC124310, bw, mi, vit, vitiligo, wh, Wh, Bhlhe32, Vitiligo

    Protein Interaction Partner: Patz1,Pax6,Pax6,Pias3,Pias3,Pick1

    Protein Size: 419

    Molecular Weight

    47 kDa

    Gene ID

    17342

    NCBI Accession

    NM_008601, NP_032627

    UniProt

    Q32MU7
You are here:
Chat with us!